1. Home
  2. TIPT vs AURA Comparison

TIPT vs AURA Comparison

Compare TIPT & AURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tiptree Inc.

TIPT

Tiptree Inc.

N/A

Current Price

$18.56

Market Cap

672.9M

Sector

Finance

ML Signal

N/A

Logo Aura Biosciences Inc.

AURA

Aura Biosciences Inc.

HOLD

Current Price

$7.40

Market Cap

797.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TIPT
AURA
Founded
2007
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
672.9M
797.5M
IPO Year
2017
2021

Fundamental Metrics

Financial Performance
Metric
TIPT
AURA
Price
$18.56
$7.40
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$20.00
AVG Volume (30 Days)
192.3K
770.0K
Earning Date
05-12-2026
05-08-2026
Dividend Yield
1.40%
N/A
EPS Growth
N/A
N/A
EPS
0.34
N/A
Revenue
$488,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$53.79
N/A
Revenue Growth
N/A
N/A
52 Week Low
$15.49
$4.73
52 Week High
$27.38
$9.54

Technical Indicators

Market Signals
Indicator
TIPT
AURA
Relative Strength Index (RSI) 54.96 50.21
Support Level $17.34 $7.27
Resistance Level $18.72 $7.83
Average True Range (ATR) 0.35 0.45
MACD 0.03 -0.04
Stochastic Oscillator 64.79 38.58

Price Performance

Historical Comparison
TIPT
AURA

About TIPT Tiptree Inc.

Tiptree Inc is a United States-based company that provides specialty insurance products and related services. It has two reportable segments: Insurance and Mortgage. The company generates the majority of its revenue from the Insurance Segment, which is engaged in designing, marketing, and underwriting specialty property and casualty insurance products incorporating value-added coverages and services for select target markets or niches. The Mortgage segment originates loans for sale to institutional investors, including GSEs and FHA/VA, and services loans on behalf of Fannie Mae, Freddie Mac, and Ginnie Mae.

About AURA Aura Biosciences Inc.

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

Share on Social Networks: